Stryker Biotech (Bone Morphogenetic Protein Business) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Stryker Biotech (Bone Morphogenetic Protein Business) General Information

Description

Developer of bone protein. The company is engaged in developing bone morphogenetic protein for treatment of long bone fractures and and lumbar spine fusion.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Acquirer
Primary Office
  • 2825 Airview Boulevard
  • Portage, MI 49002
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Stryker Biotech (Bone Morphogenetic Protein Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Stryker Biotech (Bone Morphogenetic Protein Business)‘s full profile, request access.

Request a free trial

Stryker Biotech (Bone Morphogenetic Protein Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Stryker Biotech (Bone Morphogenetic Protein Business)‘s full profile, request access.

Request a free trial